On the public citation graph
https://doi.org/10.2139/ssrn.4655407
0 signed · 21 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/cbic.200900721openalex-extracted
The Identification of a Novel Natural Activator of p300 Histone Acetyltranferase Provides New Insights into the Modulation Mechanism of this Enzyme
inferredcites →https://doi.org/10.1016/j.bcp.2004.03.045openalex-extracted
CBP and p300: HATs for different occasions
inferredcites →https://doi.org/10.1016/j.cclet.2021.02.004openalex-extracted
Design, synthesis and antitumor evaluations of nucleoside base hydroxamic acid derivatives as DNMT and HDAC dual inhibitors
inferredcites →https://doi.org/10.1016/j.cell.2012.06.013openalex-extracted
Cancer Epigenetics: From Mechanism to Therapy
inferredcites →https://doi.org/10.1016/j.chembiol.2010.03.006openalex-extracted
Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor
inferredcites →https://doi.org/10.1016/j.ejmech.2020.112861openalex-extracted
Current development of CBP/p300 inhibitors in the last decade
inferredcites →https://doi.org/10.1016/j.radonc.2014.03.015openalex-extracted
C646, a selective small molecule inhibitor of histone acetyltransferase p300, radiosensitizes lung cancer cells by enhancing mitotic catastrophe
inferredcites →https://doi.org/10.1016/j.sbi.2008.09.004openalex-extracted
Structure and chemistry of the p300/CBP and Rtt109 histone acetyltransferases: implications for histone acetyltransferase evolution and function
inferredcites →https://doi.org/10.1016/j.yexmp.2014.09.019openalex-extracted
Inhibition of p300 suppresses growth of breast cancer. Role of p300 subcellular localization
inferredcites →https://doi.org/10.1021/acs.jmedchem.9b01721openalex-extracted
Discovery of Highly Potent, Selective, and Orally Efficacious p300/CBP Histone Acetyltransferases Inhibitors
inferredcites →https://doi.org/10.1021/cr500452kopenalex-extracted
Protein Lysine Acetylation by p300/CBP
inferredcites →https://doi.org/10.1038/365855a0openalex-extracted
Phosphorylated CREB binds specifically to the nuclear protein CBP
inferredcites →https://doi.org/10.1038/nature24028openalex-extracted
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
inferredcites →https://doi.org/10.1074/jbc.r115.692020openalex-extracted
Role of Intrinsic Protein Disorder in the Function and Interactions of the Transcriptional Coactivators CREB-binding Protein (CBP) and p300
inferredcites →https://doi.org/10.1158/1538-7445.am2020-1753openalex-extracted
Abstract 1753: Targeting cancer with selective cbp/p300 bromodomain inhibitors
inferredcites →https://doi.org/10.1158/2159-8290.cd-20-0751openalex-extracted
Targeting the p300/CBP Axis in Lethal Prostate Cancer
inferredcites →https://doi.org/10.3389/fonc.2021.664403openalex-extracted
Carnosol Is a Novel Inhibitor of p300 Acetyltransferase in Breast Cancer
inferredcites →https://doi.org/10.3390/cancers13122872openalex-extracted
CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers
inferredcites →https://doi.org/10.3892/ijo.2017.4176openalex-extracted
Histone acetyltransferase p300/CBP inhibitor C646 blocks the survival and invasion pathways of gastric cancer cell lines
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.